Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure

Journal of Nuclear Medicine

Volumn 49, Issue 2, 2008, Pages 234-241

  Caldwell, James H ^a,b   Link, Jeanne M ^a   Levy, Wayne C ^a   Poole, Jeanne E ^a   Stratton, John R ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Imaging heart failure; Sudden death; Sympathetic nervous system

Indexed keywords

3 HYDROXYEPHEDRINE C 11; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE C 11; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR; CARBON 11; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METOPROLOL; NORADRENALIN DERIVATIVE; OXYGEN 15; TRACER; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DRUG METABOLISM; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART HEMODYNAMICS; HEART MUSCLE BLOOD FLOW; HUMAN; ISCHEMIC HEART DISEASE; MALE; POSITRON EMISSION TOMOGRAPHY; PRESYNAPTIC NERVE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH;

AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; EVIDENCE-BASED MEDICINE; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MYOCARDIAL ISCHEMIA; RADIOPHARMACEUTICALS; SYNAPSES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 38949110626     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.044339     Document Type: Article

References (40)

1. Francis GS, Cohn JN, Johnson G, Rector TS, Goldman S, Simon A. Plasma norepinephrine, plasma renin activity and congestive heart failure. Circulation. 1993;87(6 suppl):VI40-VI48.
2. Bristow MR, Hershberger RE, Port JD, et al. Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation. 1990;82(2 suppl):I12-I25.
3. Bristow MR, Minobe W, Rasmussen R, et al. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest. 1992;89:803-815.
4. Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler MD. Cardiac sympathetic nervous activity in congestive heart failure: evidence for increased neuronal norepinephrine release and preserved neuronal uptake. Circulation. 1993;88:136-145.
5. Glowniak JV, Kilty JE, Amara SG, Hoffman BJ, Turner FE. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J Nucl Med. 1993;34:1140-1146.
6. Eisenhofer G, Friberg P, Rundqvist B, et al. Cardiac sympathetic nerve function in congestive heart failure. Circulation. 1996;93:1667-1676.
7. Mardon K, Montagne O, Elbaz N, et al. Uptake-1 carrier downregulates in parallel with the beta-adrenergic receptor desensitization in rat hearts chronically exposed to high levels of circulating norepinephrine: implications for cardiac neuroimaging in human cardiomyopathies. J Nucl Med. 2003;44:1459-1466.
8. Inoue H, Zipes DP. Results of sympathetic denervation in the canine heart: hypersensitivity that may be arrhythmogenic. Circulation. 1987;75:877-887.
9. Inoue H, Zipes DP. Time course of denervation of efferent sympathetic and vagal nerves after occlusion of the coronary artery in the canine heart. Circ Res. 1988;62:1111-1120.
10. Vracko R, Thorning D, Frederickson RG. Fate of nerve fibers in necrotic, healing, and healed rat myocardium. Lab Invest. 1990;63:490-501.
11. Calkins H, Allman K, Bolling S, et al. Correlation between scintigraphic evidence of regional sympathetic neuronal dysfunction and ventricular refractoriness in the human heart. Circulation. 1993;88:172-179.
12. 11C-hydroxyephedrine PET coincide in heart failure [abstract]. J Am Coll Cardiol. 1996;27(suppl. A):406A.
13. 11C] hydroxyephedrine, a specific tracer for sympathetic nerve endings, and its functional correlates in congestive heart failure. Am J Cardiol. 1999;84:568-574.
14. Link JM, Stratton JR, Levy WC, et al. PET measures of pre- and post-synaptic cardiac beta adrenergic function. Nucl Med Biol. 2003;30:795-803.
15. Ungerer M, Hartmann F, Karoglan M, et al. Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation. 1998;97:174-180.
16. Bristow MR, Anderson FL, Port JD, et al. Differences in beta-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation. 1991;84:1024-1039.
17. 11C CGP-12177 to assess β-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation. 1993;87:1169-1178.
18. Wichter T, Schafers M, Rhodes CG, et al. Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. Circulation. 2000;101:1552-1558.
19. Krohn KA, Link JM, Lewellen TK, Risler R, Eenmaa J, Maier M. The use of 50 MeV protons to produce C-11 and O-15. J Labelled Cmpd Radiopharm. 1986;23:1190-1192.
20. Rosenspire KC, Haka MS, Van Dort ME, et al. Synthesis and preliminary evaluation of carbon-11-meta-hydroxyephedrine: a false transmitter agent for heart neuronal imaging. J Nucl Med. 1990;31:1328-1334.
21. 11C]CGP 12177) as a preferred radioligand for β-adrenergic receptors. Appl Radiat Isot. 1991;42:621-628.
22. 11C]-CGP 12177 from optically active precursors. J Labelled Cmpd Radiopharm. 1991;XXIX:681-690.
23. 2 in a single pass reaction. Nucl Med Biol. 1997;24:93-97.
24. 11C]-meta-hydroxyephedrine and metabolites in plasma. J Chromatogr B Biomed Sci Appl. 1997;693:31-41.
25. 11C]-S-4-(tert-butylamino- 2-hydroxypropoxy)-benzimidazol-2-one in the dog. J Chromatogr. 1991;570:361-370.
26. Delforge J, Syrota A, Lancon JP, et al. Cardiac beta-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. J Nucl Med. 1991;32:739-748.
27. Bergmann SR, Herrero P, Markham J, Weinheiner CJ, Walsh MN. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol. 1989;14:639-652.
28. 11C-meta- hydroxyephedrine (MHED): validation of a blood-tissue exchange model. J Nucl Med. 1998;39:1327-1334.
29. Delforge J. Correction of a relationship that assesses beta-adrenergic receptor concentration with PET and carbon-11-CGP 12177. J Nucl Med. 1994;35:921.
30. Schwaiger M, Kalff V, Rosenspire K, et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation. 1990;82:457-464.
31. Allman KC, Wieland DM, Muzik O, DeGrado TR, Wolfe ER, Schwaiger M. Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans. J Am Coll Cardiol. 1993;22:368-375.
32. Schafers M, Dutka D, Rhodes CG, et al. Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res. 1998;82:57-62.
33. Matsunari I, Schricke U, Bengel FM, et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation. 2000;101:2579-2585.
34. Shan K, Bick RJ, Poindexter BJ, et al. Altered adrenergic receptor density in myocardial hibernation in humans: a possible mechanism of depressed myocardial function. Circulation. 2000;102:2599-2606.
35. Kozlovskis PL, Smets MJ, Duncan RC, Bailey BK, Bassett AL, Myerburg RJ. Regional beta-adrenergic receptors and adenylate cyclase activity after healing of myocardial infarction in cats. J Mol Cell Cardiol. 1990;22:311-322.
36. Gordeladze JO, Jynge I, Borchgrevink PC, Sellevold OF. Enhanced responsiveness of the myocardial beta-adrenoceptor-adenylate cyclase system in the perfused rat heart (I). Biosci Rep. 1998;18:229-250.
37. Merlet P, Valette H, Dubois-Rande J, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471-477.
38. Pietila M, Malminiemi K, Ukkonen H, et al. Reduced myocardial carbon-11 hydroxyephedrine retention is associated with poor prognosis in chronic heart failure. Eur J Nucl Med. 2001;28:373-376.
39. Chandler WL, Mornin D, Whitten RO, et al. Insulin, cortisol, and catecholamines do not regulate circadian variations in fibrinolytic activity. Thromb Res. 1990;58:1-12.
40. Tachikawa H, Kodama M, Watanabe K, et al. Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy. Circulation. 2005;111:894-899.